1. Home
  2. IPGP vs HAE Comparison

IPGP vs HAE Comparison

Compare IPGP & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPGP
  • HAE
  • Stock Information
  • Founded
  • IPGP 1990
  • HAE 1971
  • Country
  • IPGP United States
  • HAE United States
  • Employees
  • IPGP N/A
  • HAE N/A
  • Industry
  • IPGP Semiconductors
  • HAE Medical/Dental Instruments
  • Sector
  • IPGP Technology
  • HAE Health Care
  • Exchange
  • IPGP Nasdaq
  • HAE Nasdaq
  • Market Cap
  • IPGP 3.3B
  • HAE 3.3B
  • IPO Year
  • IPGP 2006
  • HAE 1991
  • Fundamental
  • Price
  • IPGP $66.55
  • HAE $68.56
  • Analyst Decision
  • IPGP Buy
  • HAE Strong Buy
  • Analyst Count
  • IPGP 7
  • HAE 9
  • Target Price
  • IPGP $72.75
  • HAE $99.78
  • AVG Volume (30 Days)
  • IPGP 372.5K
  • HAE 578.9K
  • Earning Date
  • IPGP 05-06-2025
  • HAE 05-08-2025
  • Dividend Yield
  • IPGP N/A
  • HAE N/A
  • EPS Growth
  • IPGP N/A
  • HAE 44.54
  • EPS
  • IPGP N/A
  • HAE 3.31
  • Revenue
  • IPGP $952,918,000.00
  • HAE $1,360,824,000.00
  • Revenue This Year
  • IPGP N/A
  • HAE N/A
  • Revenue Next Year
  • IPGP $8.43
  • HAE $6.76
  • P/E Ratio
  • IPGP N/A
  • HAE $20.46
  • Revenue Growth
  • IPGP N/A
  • HAE 3.96
  • 52 Week Low
  • IPGP $48.59
  • HAE $55.30
  • 52 Week High
  • IPGP $92.21
  • HAE $94.99
  • Technical
  • Relative Strength Index (RSI)
  • IPGP 58.28
  • HAE 54.87
  • Support Level
  • IPGP $64.93
  • HAE $66.42
  • Resistance Level
  • IPGP $68.26
  • HAE $68.75
  • Average True Range (ATR)
  • IPGP 1.56
  • HAE 1.30
  • MACD
  • IPGP 0.01
  • HAE -0.26
  • Stochastic Oscillator
  • IPGP 57.71
  • HAE 45.00

About IPGP IPG Photonics Corporation

IPG Photonics Corp is a vertically integrated developer and manufacturer of high-performance fiber lasers, fiber amplifiers, and diode lasers, which are used in diverse applications in the manufacturing, automotive, industrial, aerospace, semiconductor, and consumer end markets. A large majority of the firm's revenue is derived from materials processing applications for fiber lasers, including cutting and welding, marking and engraving, and micro-processing. The company generates a majority of its revenue from China and also has its presence in North America, Japan, Germany, and other markets.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: